These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3271619)

  • 1. Effect of diabetes mellitus on salivary paracetamol elimination.
    Adithan C; Danda D; Swaminathan RP; Indhiresan J; Shashindran CH; Bapna JS; Chandrasekar S
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):465-71. PubMed ID: 3271619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary paracetamol elimination in patients with congestive cardiac failure.
    Kumar NP; Sethuraman KR; Chandrasekar S; Ray K; Adithan C; Shashindran CH
    Clin Exp Pharmacol Physiol; 1987 Sep; 14(9):731-4. PubMed ID: 3442954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of type I and type II diabetes mellitus on antipyrine elimination.
    Adithan C; Danda D; Shashindran CH; Bapna JS; Swaminathan RP; Chandrasekar S
    Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):755-8. PubMed ID: 2626081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short course chemotherapy on salivary paracetamol elimination.
    Madhusudanarao K; Bapna JS; Adithan C; Ray K; Venkatadri N; Kamatchi GL; Seetharaman ML; Bahadur P
    Clin Exp Pharmacol Physiol; 1988 Aug; 15(8):639-43. PubMed ID: 3271629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary paracetamol elimination kinetics during the menstrual cycle.
    Somaja L; Thangam J
    Br J Clin Pharmacol; 1987 Mar; 23(3):348-50. PubMed ID: 3567050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of type II diabetes mellitus on theophylline elimination.
    Adithan C; Sriram G; Swaminathan RP; Krishnan M; Bapna JS; Chandrasekar S
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):258-60. PubMed ID: 2737793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of short surgical procedures on salivary paracetamol elimination.
    Ray K; Adithan C; Bapna JS; Kangle PR; Ray K; Ramakrishnan S
    Br J Clin Pharmacol; 1985 Aug; 20(2):174-6. PubMed ID: 4041337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracetamol elimination in patients with non-insulin dependent diabetes mellitus.
    Kamali F; Thomas SH; Ferner RE
    Br J Clin Pharmacol; 1993 Jan; 35(1):58-61. PubMed ID: 8448070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of trichloroethylene anaesthesia on salivary paracetamol elimination.
    Ray K; Sahana CC; Chaudhuri SB; De GC; Chatterjee K
    Indian J Physiol Pharmacol; 1993 Jan; 37(1):79-81. PubMed ID: 8449552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of halothane anaesthesia on salivary elimination of paracetamol.
    Ray K; Adithan C; Bapna JS; Kamatchi GL; Ray K; Mehta RB
    Eur J Clin Pharmacol; 1986; 30(3):371-3. PubMed ID: 3732379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva.
    Issa MM; Nejem RM; El-Abadla NS
    Clin Drug Investig; 2006; 26(4):223-6. PubMed ID: 17163255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of saliva and serum paracetamol levels using a simple spectrophotometric method.
    Adithan C; Thangam J
    Br J Clin Pharmacol; 1982 Jul; 14(1):107-9. PubMed ID: 7104162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine metabolism in patients with diabetes mellitus.
    Murali KV; Adithan C; Shashindran CH; Gambhir SS; Chandrasekar S
    Clin Exp Pharmacol Physiol; 1983; 10(1):7-13. PubMed ID: 6839551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system.
    Idkaidek N; Arafat T
    Drug Res (Stuttg); 2014 Oct; 64(10):559-62. PubMed ID: 24452519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iron on the pharmacokinetics of paracetamol in saliva.
    Issa MM; Nejem RM; Shanab AA
    Pak J Biol Sci; 2013 Dec; 16(24):2050-3. PubMed ID: 24517028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose Level Estimation in Diabetes Mellitus By Saliva: A Bloodless Revolution.
    Kadashetti V; Baad R; Malik N; Shivakumar KM; Vibhute N; Belgaumi U; Gugawad S; Pramod RC
    Rom J Intern Med; 2015; 53(3):248-52. PubMed ID: 26710500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of paracetamol and its conjugates in Chinese non-insulin-dependent diabetic patients with renal impairment.
    Chan MT; Anderson PJ; Chan JC; Lau GS; Critchley JA
    Eur J Clin Pharmacol; 1997; 52(4):285-8. PubMed ID: 9248766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and saliva secretion of paracetamol in healthy male Nigerians.
    Babalola CP; Oladimeji FA; Femi-Oyewo MN
    West Afr J Med; 2004; 23(1):10-4. PubMed ID: 15171517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of salivary α2 macroglobulin in patients with type 2 diabetes mellitus.
    Feng JK; Lu YF; Li J; Qi YH; Yi ML; Ma DY
    Genet Mol Res; 2015 Mar; 14(1):2268-74. PubMed ID: 25867373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.